Plenary Session: Next Generation Advances in Neuroscience Research
11 November, 2020 2:00PM - 3:00PM CET / 8:00AM - 9:00AM ET
This panel brings together executives that are each taking new approaches to treating neurodegenerative disorders. Attendees can expect the session to center around the current challenges in neurodegenerative disease treatment and the anticipated next steps in global research.
Moderator: Danielle Friend, PhD, Senior Director, Science and Regulatory Affairs, BIO
Speakers:
- Tor-Kristian Jenssen, Head, Research & Development, PubGene
- Peter Laivins, Chief Commercial Officer, Alzheon
- Professor Charalampos Tzoulis, Prof. of Neurology & Neurogenetics, Neuro-SysMed